1974 - Fellow of John Simon Guggenheim Memorial Foundation
His main research concerns Internal medicine, Schizophrenia, Neuroscience, Alzheimer's disease and Psychosis. His Internal medicine research includes themes of Endocrinology and Surgery. His Schizophrenia study incorporates themes from Genetics, Genome-wide association study, Copy-number variation, Clinical psychology and Pediatrics.
His Neuroscience research focuses on subjects like White matter, which are linked to Diffusion MRI, Neurology and Superior frontal gyrus. Kenneth L. Davis interconnects Psychiatry, Dementia and Degenerative disease in the investigation of issues within Alzheimer's disease. His Psychosis research is multidisciplinary, incorporating perspectives in Cognition, Abnormality, Neuropathology, Cognitive disorder and Dopamine receptor D3.
Kenneth L. Davis mainly investigates Internal medicine, Endocrinology, Schizophrenia, Neuroscience and Psychiatry. His Internal medicine research incorporates themes from Depression and Cardiology. His work on Cerebrospinal fluid expands to the thematically related Endocrinology.
His Schizophrenia study integrates concerns from other disciplines, such as Haloperidol, Psychosis and Clinical psychology. The study incorporates disciplines such as Central nervous system disease, Degenerative disease and Dementia in addition to Alzheimer's disease. The various areas that Kenneth L. Davis examines in his Physostigmine study include Placebo and Anesthesia.
His scientific interests lie mostly in Schizophrenia, Neuroscience, Internal medicine, Psychosis and Genetics. His study in Schizophrenia is interdisciplinary in nature, drawing from both Bipolar disorder, Cognition, Disease and Human brain. His Cognition research includes themes of Developmental psychology and Clinical psychology.
His Neuroscience research is multidisciplinary, incorporating elements of NMDA receptor and White matter. In his study, Glutamate receptor is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine. In his research, Clinical Dementia Rating is intimately related to Cognitive decline, which falls under the overarching field of Alzheimer's disease.
Kenneth L. Davis mostly deals with Neuroscience, Schizophrenia, Internal medicine, Psychosis and Oligodendrocyte. His study looks at the intersection of Neuroscience and topics like White matter with Diffusion MRI and Neurology. His Schizophrenia study combines topics in areas such as Genetics, Genome-wide association study, Glutamate receptor, Disease and Cognitive disorder.
Kenneth L. Davis has researched Disease in several fields, including Biological plausibility, Allele and Psychiatric genetics. His Internal medicine research integrates issues from Endocrinology and Pathology. The subject of his Psychosis research is within the realm of Psychiatry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters.
Nature (2014)
A new rating scale for Alzheimer's disease.
Wilma G. Rosen;Richard C. Mohs;Kenneth L. Davis.
American Journal of Psychiatry (1984)
Dopamine in Schizophrenia: A Review and Reconceptualization
Kenneth L. Davis;René S. Kahn;Grant Ko;Michael Davidson.
American Journal of Psychiatry (1991)
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.
P. Ponte;P. Gonzalez DeWhitt;J. Schilling;J. Miller.
Nature (1988)
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Jan Näslund;Vahram Haroutunian;Richard Mohs;Kenneth L. Davis.
JAMA (2000)
Serotonergic Studies in Patients with Affective and Personality Disorders: Correlates with Suicidal and Impulsive Aggressive Behavior
Emil F. Coccaro;Larry J. Siever;Howard M. Klar;Gail Maurer.
Archives of General Psychiatry (1989)
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
Peter Szatmari;Andrew D. Paterson;Lonnie Zwaigenbaum;Wendy Roberts.
Nature Genetics (2007)
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
Science (2010)
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.
Yaron Hakak;John R. Walker;Cheng Li;Wing Hung Wong.
Proceedings of the National Academy of Sciences of the United States of America (2001)
Neuropsychopharmacology : The Fifth Generation of Progress
Kenneth L. Davis;Dennis S. Charney;Joseph T. Coyle;Charles B. Nemeroff.
(2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Icahn School of Medicine at Mount Sinai
Eli Lilly (United States)
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
University of Miami
Icahn School of Medicine at Mount Sinai
Duke University
University of Chicago
Uniformed Services University of the Health Sciences
Virginia Commonwealth University
Nanyang Technological University
Microsoft (United States)
IBM (United States)
University of California, Los Angeles
University of Aveiro
University of Queensland
University of Bremen
University of Iowa
Charité - University Medicine Berlin
Scripps Institution of Oceanography
Queen's University
University of Freiburg
Trinity College Dublin
Humboldt State University
National University of Singapore
The University of Texas at Austin